The SELECT trial demonstrated that semaglutide reduced major adverse cardiovascular events by 20% in adults with established cardiovascular disease and obesity, without any requirement for type 2 diabetes [5]
Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements
they'll be healthier, they'll have a better quality of life, and hopefully, there will be less costs because of the costs associated with these complications as well
If symptoms of diabetic ketoacidosis (DKA) developsuch as nausea, vomiting, abdominal pain, excessive thirst, difficulty breathing, confusion, or unusual fatiguepatients must seek urgent same-day medical assessment
10.1006/bbrc.1993.2226 [DOI] [PubMed] [Google Scholar] 61.Harmar J